Van der Sand LC - Search Results

1

SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians.

Sortica VA, Fiegenbaum M, Lima LO, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. Sortica VA, et al. Among authors: van der sand lc. Clin Chem Lab Med. 2012 Mar;50(3):441-8. doi: 10.1515/cclm.2011.804. Clin Chem Lab Med. 2012. PMID: 22505549

2

Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes.

Fiegenbaum M, Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. Fiegenbaum M, et al. Among authors: van der sand lc. Pharmacogenomics J. 2005;5(6):359-64. doi: 10.1038/sj.tpj.6500334. Pharmacogenomics J. 2005. PMID: 16158080

3

ESR1 polymorphisms and statin therapy: a sex-specific approach.

Smiderle L, Fiegenbaum M, Hutz MH, Van Der Sand CR, Van Der Sand LC, Ferreira ME, Pires RC, Almeida S. Smiderle L, et al. Among authors: van der sand lc. Pharmacogenomics J. 2016 Nov;16(6):507-513. doi: 10.1038/tpj.2015.60. Epub 2015 Aug 25. Pharmacogenomics J. 2016. PMID: 26302681

4

PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.

de Souza JA, Menin A, Lima LO, Smiderle L, Hutz MH, Van Der Sand CR, Van Der Sand LC, Ferreira ME, Pires RC, Almeida S, Fiegenbaum M. de Souza JA, et al. Among authors: van der sand lc. Clin Biochem. 2015 Nov;48(16-17):1039-44. doi: 10.1016/j.clinbiochem.2015.06.009. Epub 2015 Jun 12. Clin Biochem. 2015. PMID: 26079344

5

Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.

Smiderle L, Lima LO, Hutz MH, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Almeida S, Fiegenbaum M. Smiderle L, et al. Among authors: van der sand lc. Arq Bras Cardiol. 2014 Jul;103(1):33-40. doi: 10.5935/abc.20140085. Arq Bras Cardiol. 2014. PMID: 25120083 Free PMC article.

6

Influence of PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms on the lipid-lowering efficacy and safety of statin therapy.

Lima LO, Bruxel EM, Hutz MH, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Fiegenbaum M, Almeida S. Lima LO, et al. Among authors: van der sand lc. Arq Bras Endocrinol Metabol. 2013 Oct;57(7):513-9. doi: 10.1590/s0004-27302013000700003. Arq Bras Endocrinol Metabol. 2013. PMID: 24232815

7

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.

Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. Fiegenbaum M, et al. Among authors: van der sand lc. Clin Pharmacol Ther. 2005 Nov;78(5):551-8. doi: 10.1016/j.clpt.2005.08.003. Epub 2005 Sep 26. Clin Pharmacol Ther. 2005. PMID: 16321621

8

Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.

Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. Fiegenbaum M, et al. Among authors: van der sand lc. Clin Chim Acta. 2005 Dec;362(1-2):182-8. doi: 10.1016/j.cccn.2005.06.005. Epub 2005 Jul 20. Clin Chim Acta. 2005. PMID: 16038892

9

[Surgical myocardial revascularization in young patients].

Gustavo Thomé L, Vitola D, Van der Sand LC, Ricardo Sant'Anna J, Kalil RA, Prates P, Lucchese FA, Nesralla IA, Pereira E, Rodrigues R. Gustavo Thomé L, et al. Among authors: van der sand lc. Arq Bras Cardiol. 1996 Feb;66(2):69-73. Arq Bras Cardiol. 1996. PMID: 8734862 Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page